Evaluation of the effect of the neurotoxin MPTP and the antiparkinsonian drug hemantane on the DNA integrity in the brain structures of C57BL/6 mice
Hemantane (N-adamant-2-yl-hexamethylenimine hydrochloride) is an antiparkinsonian drug with a multicomponent mechanism of action, including a modulating effect on the activity of dopamine and serotonergic mediator systems, a selective inhibitory effect on MAO-B, properties of a low-affinity non-comp...
Saved in:
| Main Authors: | E. A. Anisina, A. K. Zhanataev, A. V. Nepoklonov, S. O. Kotelnikova, E. A. Valdman |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC “Publisher OKI”
2022-02-01
|
| Series: | Фармакокинетика и Фармакодинамика |
| Subjects: | |
| Online Access: | https://www.pharmacokinetica.ru/jour/article/view/299 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EInvestigation of antiparkinsonian, anti-inflammatory and analgesic effects of ADK-1058, a metabolite of hemantane, in comparison with hemantane
by: I. G. Kapitsa, et al.
Published: (2016-09-01) -
Effects of Hemantane upon the level of lipid peroxidation in brain in experimental parkinsonian syndrome
by: E. A. Ivanova, et al.
Published: (2016-09-01) -
Mycobacterium bovis deleted in mce2 and phoP loci protects C57BL/6 mice against tuberculosis
by: Elizabeth García, et al.
Published: (2016-08-01) -
The study of antiparkinsonian activity of the combination of ladasten with fabomotizole in paraquat-induced model of parkinsoian syndrome
by: V. E. Marievskii, et al.
Published: (2025-05-01) -
Differences of the 6N and 6J Substrains of C57BL/6 Mice in the Development of Experimental Autoimmune Encephalomyelitis
by: Ana Isabel Álvarez‐López, et al.
Published: (2025-07-01)